Pharmafile Logo

Clinical Trial Enrollment

The good, the bad and the ugly

Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends

- PMLiVE

Boehringer abandons PDE-targeted Alzheimer’s drug

But will keep testing the candidate in schizophrenia

Roche Basel Switzerland

NICE backs Roche’s Gazyvaro after initial rejection

An undisclosed discount swayed the cost-effectiveness body

Novartis telemedicine service to be ramped up in Ghana

Country's health service selects it as part of the national eHealth strategy

- PMLiVE

NICE backs EUSA’s RCC treatment Fotivda

The UK’s cost-effectiveness watchdog recommends its first-line use

- PMLiVE

Avril Lee joins Burson-Marsteller in global role

Based in the UK, she joins the firm as its deputy global healthcare practice chair

- PMLiVE

A catalyst for change

China’s plan to boost innovation and improve drug accessibility

- PMLiVE

Rubius Therapeutics adds to its board of directors

Francis Cuss and Catherine Sohn join the US biotech

To track disease, follow the money

Using paper currency to track infections sounds like a clever idea. But we think the smart money is on your phone.

Life Healthcare Communications

Webcast: Rich in potential – Exploring the opportunity for nutritionals in emerging markets

Watch the webcast: http://bit.ly/2oTpzFjA shift to preventative health has seen nutritionals emerge as a rapidly developing area in recent years. But while growth begins to level off in more established territories,...

Inizio

A researcher’s guide to Key Driver Analysis

Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business

Inizio

Research Partnership sends a cheque for $10,000 to Forever Angels

Helping them in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links